Rahul Ballal - Insider Trading & Ownership

Entity
Individual
Location
116 Huntington Avenue, 6 Th Floor, Boston, MA
Summary
The estimated net worth of Rahul Ballal is at least $1M dollars as of August 13, 2024. Rahul Ballal is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $563K. Rahul Ballal is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $440K.
All Insider Reports
All Insider Reports

Ownership of Rahul Ballal

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. Director $563K -$1.95M -77.6% Apr 10, 2024
AGIO AGIOS PHARMACEUTICALS, INC. Director $440K Aug 11, 2024

Insider Transactions Reported by Rahul Ballal:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.